LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
- EBITDA, 2025
- $75M
- YoY, 2025
- +491.9%
- 5-year CAGR
- +3.4%
- 10-year CAGR
- +9.6%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $75M | +491.9% |
| 2024 | $13M | −73.9% |
| 2023 | $48M | −11.2% |
| 2022 | $55M | −64.8% |
| 2021 | $155M | +145.2% |
| 2020 | $63M | −92.3% |
| 2019 | $825M | +367.6% |
| 2018 | $177M | +123.3% |
| 2017 | $79M | +43.2% |
| 2016 | $55M | +84.2% |
| 2015 | $30M | +34.4% |
| 2014 | $22M | +26.6% |
| 2013 | $18M | +502.9% |
| 2012 | $2.9M | +52.7% |
| 2011 | $1.9M | — |
| 2010 | −$27M | — |
| 2009 | −$5.3M | — |